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Abstract
Background: Recently, a clone of MRSA with clonal complex 398 (CC398) has emerged that is related to an extensive
reservoir in animals, especially pigs and veal calves. It has been reported previously that methicillin-susceptible variants of
CC398 circulate among humans at low frequency, and these have been isolated in a few cases of bloodstream infections
(BSI). The purpose of this study was to determine the prevalence of S. aureus CC398 in blood cultures taken from patients in
a geographic area with a high density of pigs.
Methodology/Principal Findings: In total, 612 consecutive episodes of S. aureus BSI diagnosed before and during the
emergence of CC398 were included. Three strains (2 MSSA and 1 MRSA) that were isolated from bacteremic patients
between 2010–2011 were positive in a CC398 specific PCR. There was a marked increase in prevalence of S. aureus CC398
BSI isolated between 2010–2011 compared to the combined collections that were isolated between 1996–1998 and 2002–
2005 (3/157, 1.9% vs. 0/455, 0.0%; p= 0.017).
Conclusions/Significance: In conclusion, in an area with a relative high density of pigs, S. aureus CC398 was found as a
cause of BSI in humans only recently. This indicates that S. aureus CC398 is able to cause invasive infections in humans and
that the prevalence is rising. Careful monitoring of the evolution and epidemiology of S. aureus CC398 in animals and
humans is therefore important.
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Introduction
Traditionally, methicillin-resistant Staphylococcus aureus (MRSA)
has been considered a hospital associated pathogen. Since the end
of the last century, MRSA has expanded its territory to the
community causing severe infections in previously healthy persons
all over the world [1–2]. In 2003 a new clone of MRSA was first
identified that was related to an extensive reservoir in pigs and
cattle [3]. People who are in direct contact with pigs and veal
calves have high carriage rates of such MRSA (23% and 29%,
respectively) [3–4]. The livestock-associated MRSA CC398 strains
are characterized by being non-typeable by pulsed-field gel
electrophoresis (PFGE) and are, therefore, sometimes referred to
as non-typeable MRSA (NT-MRSA) [5]. Using multi locus
sequence typing (MLST) these strains all belong to the sequence
type 398. Remarkably, S. aureus CC398 harbors several staphy-
lococcal cassette chromosome mec (SCCmec) types, suggesting that
the resistance cassette was acquired on multiple unrelated
occasions [5].
Livestock is the first clearly defined non-human reservoir of
MRSA in the community. In the Netherlands MRSA CC398 was
first detected in 2003, and by the end of 2007 nearly 30% of all
newly identified MRSA in humans in the Netherlands were of this
type, suggesting a recent and very rapid spread [6]. MRSA CC398
is now considered a zoonotic pathogen, affecting mainly people
who work with pigs and veal calves. If this strain can spread
successfully from human to human and also cause diseases in
healthy individuals it might constitute a significant public health
problem in the near future.
A typing method for S. aureus, based upon length polymorphism
of the 16S–23S spacer region has been described previously.
Although shown to be effective and reproducible [7], this method
has not been widely implemented. It is based upon the fact that
every S. aureus strain has 5 or 6 spacer regions in its chromosome.
The length of the individual regions varies within the chromo-
some, so when amplified and sorted by length using agarose gel
electrophoresis, each strain produces an individual pattern of
bands. Typing based on these spacer patterns has been shown to
correlate well with traditional typing methods [8], with discrim-
PLOS ONE | www.plosone.org 1 October 2012 | Volume 7 | Issue 10 | e41855
inatory power comparable to that of MLST [9–10]. To confirm
the results of the 16S–23S spacer fingerprint analysis, we
additionally performed two specific polymerase chain reactions
(PCR) for the detection of S. aureus CC398 isolates as described
previously [11].
Recently, van Belkum and colleagues reported that methicillin-
susceptible S. aureus (MSSA) isolates homologous to the MRSA
CC398 were found among isolates derived from bacteremic
patients (3 [2.1%] of 146) [12]. However, this study was based on a
strain collection obtained from inhabitants of a densely populated,
urban area. Moreover, the strains were not from consecutive
episodes of bloodstream infections (BSI), which may have caused
selection bias. The purpose of the current study was to determine
the prevalence of S. aureus CC398 in consecutive BSI episodes
from patients in an area with a high density of pigs.
Materials and Methods
Ethics Statement
Medical ethics review was not required for this study according
to the Dutch Medical Research Involving Human Subjects Act
(article 1, paragraph 1, section b of the WMO) due to the fact that
patients were not physically involved in this study. In addition,
privacy of patients was provided by coding all tested isolates
according to the requirements of the National Privacy Regulations
in the Netherlands and thus waived the need for consent. All blood
cultures were taken routinely from patients with body tempera-
tures higher than 39uC and symptoms of BSI for screening of
micro-organisms. Isolates of the St. Elisabeth Hospital and
Amphia Hospital were kindly provided by Anton Buiting and
Jan Kluytmans, respectively.
Strain Collections
Three independent collections with a total of 612 S. aureus
isolates from patients with BSI were tested. The patients were
hospitalized in one of two hospitals (St. Elisabeth Hospital, Tilburg
or Amphia Hospital, Breda, the Netherlands). The cities of
Tilburg and Breda are located in the southeast of the Netherlands
with a high density of pigs, i.e. approximately 1,000 pigs per
square kilometer [13]. The first collection consisted of 250 S. aureus
strains that were isolated from consecutive episodes of BSI that
occurred between January 1996 and February 1998, before
MRSA CC398 had been reported. The second collection
consisted of 205 S. aureus strains that were isolated from
consecutive episodes of BSI that occurred between August 2002
and August 2005, when MRSA CC398 emerged in the Nether-
lands. The third collection comprised 157 S. aureus isolates that
were isolated from consecutive episodes of BSI that occurred
between January 2010 and April 2011, when MRSA CC398 was
the most frequently observed MRSA variant in the hospitals
involved. Only one isolate was included per patient per bacteremic
episode. All isolates were identified by a latex agglutination test
(Staphaurex Plus; Murex Diagnostics Ltd., Dartford, England),
and by the detection of DNase (DNase agar; Oxoid Ltd.,
Basingstoke, England). The blood cultures isolates were classified
as methicillin-susceptible (MIC of oxacillin #2 mg/ml) at the time
of collection by broth micro-dilution susceptibility testing per-
formed according to CLSI standards [14]. Resistance profiles to
21 antimicrobial agents were determined with the VITEK system
(bioMe´rieux SA, Craponne, France) for all confirmed S. aureus
strains according to the manufacturer’s instructions.
Samples and Microbiological Procedures
The isolates were stored at 280uC in MicrobankTM (Pro-Lab
Diagnostics) preservation system until they were tested. All strains
were cultured overnight at 35uC on Columbia agar plates with 5%
sheep blood to obtain fresh growth. A suspension with an optical
density of 1.0 McFarland was made in 2 ml of 0.75% NaCl. From
this suspension 500 ml was centrifuged at 14,000 rpm for
3 minutes in an Eppendorf centrifuge. The supernatant was
removed and the pellet was resuspended in 200 ml distilled water
(Baxter Healthcare SA, Zurich, Switzerland) by vortexing. This
hypotonic fluid caused sufficient lysis of S. aureus. Subsequently, the
suspension was centrifuged at 14,000 rpm for 3 minutes. The
supernatant was used for PCR amplification without further
processing.
16S–23S spacer fingerprint analysis
For amplification of the 16S–23S rDNA spacer regions, two
primers were constructed in conserved regions of the 16S and 23S
rRNA genes, as described previously [7]. Each PCR mixture with
a final volume of 15 ml contained, 1 ml of DNA, 16 SuperTaq
Buffer (HT Biotechnology Ltd, Cambridge, England), 0.25 U of
SuperTaq polymerase (HT Biotechnology Ltd), 1.5 mM MgCl2,
67 mM deoxynucleotide triphosphates (HT Biotechnology Ltd),
0.5 ml of 1.25% bovine serum albumin and 1 mM of each primer
[15]. The amplification was carried out on a 7500 Real-Time
PCR System (Applied Biosystems, Foster City, USA). Cycling
conditions for PCR were: 72uC for 2 min, 35 cycles of 94uC for
30 sec, 56uC for 45 sec, 72uC for 1 min and a final extension at
72uC for 10 min.
Subsequently, 7 ml of PCR product was mixed with 5 ml of
loading buffer and separated on a 2.0% agarose gel. Electropho-
resis was performed at 300 V during 90 minutes. Fragments
lengths were sized using a 100 bp ladder DNA marker (Invitrogen,
Carlsrad, USA). Next, band patterns were visualized using a UV
Transilluminator (BioDoc-It System UVP, Upland, USA). Total
time needed from cultured strains to spacer fingerprints was about
4 hours. This typing method for S. aureus has recently been
validated using an extensive collection of strains and could detect
all non-typeable MRSA in that collection [15]. The MRSA
CC398 control strain used in our assay was isolated from a pig
farmer and was non-typeable with PFGE using the restriction
enzyme SmaI. This strain had a spa-type t108 and contained the
SCCmec type V. Discrimination of MRSA CC398 from other S.
aureus strains using spacer fingerprints is easy due to the detection
of the 539 bp fragment that is unique to MRSA CC398 strains.
This method was only applied on the strains isolated before 2007.
CC398 specific PCR
The CC398 specific primers C01F and C01R were used as
described previously in order to detect S. aureus CC398 strains by
PCR [10]. In addition, a CC398 specific probe C01P-FAM (FAM-
GTCAGTATGAATTGCGGTATG-BHQ1) was constructed to
visualize DNA amplification by real-time PCR. For amplification
of S. aureus sequence, the primers A04F and A04R were used as
described previously to check all tested strains for amplifiable S.
aureus DNA [10]. Furthermore, probe A04P-YY (Yakima Yellow-
GAGATTTGAGTTTGTGATACACCTGA-BHQ1) was con-
structed to visualize DNA amplification in real-time. Each PCR
mixture with a final volume of 25 ml contained, 2 ml of DNA and
12.5 ml of TaqManH Fast Universal PCR Master Mix (Applied
Biosystems, Foster City, USA). For the CC398 specific PCR,
concentrations of 600 nM of primer C01F, 600 nM of primer
C01R and 150 nM of probe C01P-FAM were used. For the S.
aureus specific PCR, concentrations of 900 nM of primer A04F,
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400 nM of primer A04R and 100 nM of probe A04P-YY were
used. The amplification was carried out on a 7500 Real-Time
PCR System (Applied Biosystems, Foster City, USA). PCRs were
performed using the following cycling protocol: 95uC for 10 min,
followed by 35 cycles of 95uC for 15 sec, 58uC (C01 primers) or
54uC (A04 primers) for 30 sec, 60uC for 1 min. All 612 S. aureus
strains were analyzed with the CC398 specific PCR.
Genotyping of S. aureus CC398 strains. S. aureus
CC398 strains were genotyped by staphylococcal protein A (spa)
typing [16].
Results
In total, 612 S. aureus BSI were diagnosed in 367 males and 245
females. The vast majority were methicillin-susceptible (MSSA),
610 cases (99.7%) versus 2 cases of MRSA (0.3%). The MRSA
cases were both from the most recent collection. The strains from
the first and second collection were typed using the 16S–23S
spacer fingerprint analysis, which showed that none of the 455 S.
aureus strains had a fingerprint that corresponded to the MRSA
CC398. The spacer fingerprints were digitalized and compared
using the BioNumerics software package (Applied Maths, Sint-
Martens-Latem, Belgium). Typically, MRSA CC398 strains were
characterized by the presence of fragments of 369, 386, 399, 520,
539 and 601 base pairs (bp) in length. The 539 bp fragment was
encountered only in livestock-associated strains [15].
To confirm the results of the 16S–23S spacer fingerprint
analysis, a CC398 specific PCR protocol was performed on all 612
S. aureus strains. All strains were positive in the S. aureus specific
PCR, demonstrating that all 612 DNA samples used for PCR
contained amplifiable S. aureus DNA. In addition, CC398 specific
PCR analysis demonstrated that 3 out of these 612 S. aureus isolates
(0.5%) were positive using the protocol. Prevalence was the highest
among MRSA (1/2, 50% vs. 2/610, 0.3% for MSSA; p=0.010).
The three S. aureus CC398 strains (1 MRSA strain originated from
Tilburg and 2 MSSA strains of which one originated from Tilburg
and one from Breda) all belonged to the third collection which was
obtained between January 2010 and April 2011.
The prevalence of S. aureus CC398 BSI increased recently. A
significantly higher prevalence was found in the most recent
collection compared with the older collections (3/157, 1.9% vs. 0/
455, 0.0%; p=0.017). We found only one MRSA isolate with the
typical pig-borne spa-type t011. The MRSA strain was isolated in
Tilburg in March 2010 and was resistant to tetracycline,
trimethoprim/sulfadiazine and gentamicin. Examination of the
patient history revealed no known contact with livestock. The
patient was a 72-year-old woman with an infected shoulder
prosthesis. The two MSSA CC398 isolates found in our study had
both spa-type t571 and were only resistant to erythromycin. These
two cases were hospital-acquired and included 1 case of catheter-
associated bloodstream infection observed in a 71-year-old woman
with complicated perforation of the intestines (isolated in Breda in
February 2011), and 1 case following cholecystitis in a 84-year-old
woman (recovered in Tilburg in November 2010). None of the
three S. aureus CC398 isolates were positive for the Panton-
Valentine Leukocidin (PVL) gene. The mode of acquisition of the
S. aureus CC398 isolates by our 3 patients remains unclear.
To ensure that both protocols used in this study can detect S.
aureus CC398, five of the six MSSA CC398 strains found in the
study of van Belkum et al. [12] were analyzed using the 16S–23S
spacer fingerprint analysis protocol and the CC398 specific PCR.
Both strains isolated from the nose swabs and the three strains
isolated from blood cultures showed a 16S–23S spacer fingerprint
that corresponded to our MRSA CC398 control strain (data not
shown). Moreover, these five strains as well as our positive control
strain were also positive in both the S. aureus specific and the
CC398 specific PCR.
Discussion
A large collection of consecutive isolates of S. aureus BSI episodes
in an area with a high density of pigs revealed the presence of S.
aureus CC398 in blood cultures. We demonstrated that three of the
612 S. aureus strains isolated from bacteremic patients living in an
area with a high density of pigs belong to CC398. These three
strains were all isolated in 2010–2011. Conversely, none of the 455
strains that were isolated in 1996–1998 and 2002–2005 belong to
CC398. Therefore, the present study suggests a recent emergence
among Dutch patients of BSI with CC398, a Staphylococcus aureus
strain formerly found primarily in association with pigs [12].
In accordance to our findings, van Belkum and colleagues [12]
found that CC398 is rare among Dutch MSSA strains colonizing
healthy persons (2 [0.2%] of 829 strains). However, a higher
number of MSSA isolates belonging to clonal complex 398 were
found among bacteremic patients (3 [2.1%] of 146; p=0.026). The
prevalence of MSSA CC398 in human blood cultures was
comparative with the prevalence found in our study. Interestingly,
all three S. aureus CC398 strains found by van Belkum and
colleagues were isolated from bacteremic patients in Rotterdam
had also spa-type t571. The authors were unable to find an
epidemiological link between these 3 patients. The strains were
obtained from different patients in different medical departments
over an extended period. Notably, spa-type t571 CC398 has been
found recently in MSSA carriage isolates from New York City
[17], and the Dominican Republic [17], and also in clinical MSSA
isolates from northern Manhattan [18], Colombia [19], the
Netherlands [12], and France [20]. A recent study even postulates
that MRSA CC398 originated in human as MSSA, with spa-type
t571 disproportionately common among human-associated iso-
lates [21]. The lineage appears to have undergone a rapid
radiation in conjunction with the jump from humans to livestock.
This jump was accompanied by the loss of phage-carried human
virulence genes, which likely attenuated its zoonotic potential [21].
Another recently published study demonstrated that the
incidence of S. aureus CC398 BSI is rapidly increasing. Valentin-
Domelier et al. reported 18 S. aureus CC398 BSI during a four-year
period in three noncontiguous French regions [22]. S. aureus
CC398 incidence showed a seven-fold increase during the study
period (0.002 per 1,000 patient days in 2007 vs. 0.014 in 2010).
Seventeen out of the 18 BSI isolates were methicillin-susceptible
and additional spa-typing identified six related spa-types. The two
spa-types t571 and t1451, that are infrequently associated with pig-
borne isolates, were found with 10 and 4 BSI isolates, respectively.
No isolate was assigned to classical pig-borne spa-types, such as
t011, t034 or t108. None of the 18 CC398 isolates were positive
for the PVL gene.
At present, it is unclear whether MRSA CC398 is easily
transmissible from human to human. However, recent published
studies demonstrate that MRSA CC398 is less transmissible than
other MRSA strains [23–24]. In contrast, a recent study reported
that CC398 is a frequent source of MSSA infections in northern
Manhattan and is readily transmitted between individuals in
households [18]. Also the virulence of S. aureus CC398 is still a
matter of debate. There are indications that MRSA CC398 causes
infections less frequently than other MRSA strains [24–25]. On
the other hand, there are increasing numbers of case reports of
severe invasive infections due to MRSA CC398, such as
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endocarditis and necrotizing pneumonia [26–27]. In addition,
these recent invasive infections are mostly associated with non-pig-
borne isolates [11,20,22]. To determine whether the potential
impact of MRSA CC398 can be derived from the existence of
genetically homologous MSSA strains among bacteremic patients,
we determined the prevalence of S. aureus CC398 in positive blood
cultures taken from patients in an area with a high prevalence of
pigs using 16S–23S spacer fingerprint analysis and also a CC398
specific PCR. The historical occurrence of S. aureus CC398 in
blood culture isolates may provide an estimate for the potential
impact of MRSA CC398 on public health.
The results of our study have two important limitations. Firstly,
approximately one third of the S. aureus BSI of the earlier period
1996–1998 were community-associated. The proportion of
community-associated BSI increased to 50% in the period
2002–2005 and 2010–2011, respectively. One might expect that
MRSA CC398 would be found more frequently in community-
associated cases as compared to healthcare-associated cases based
on the epidemiology known to date. Therefore, the likelihood to
demonstrate the presence of S. aureus CC398 in blood culture may
be reduced by including more healthcare-associated cases.
Secondly, the first collection of strains was isolated in 1996–
1998. This may have been too early as the first case of MRSA
CC398 was reported only in 2003. It is possible that S. aureus
CC398 was not present in livestock as well as humans in the
Netherlands at that time. Considering the findings of Armand-
Lefevre et al. this possibility is highly unlikely [28]. They found
MSSA CC398 strains that were isolated from swine infections and
also from healthy pig farmers between 1996–2002. MSSA CC398
was retrieved from 6 out of the 44 (13.6%) studied isolates from
healthy pig farmers. In addition, four of the 14 (28.6%) isolates
which were derived from a swine infection were MSSA CC398.
The second collections of strains were isolated between 2002–2005
and 2010–2011 when MRSA CC398 was present in our country.
In conclusion, the rapid emergence of MRSA CC398 in the
Netherlands is worrying [3]. The first isolate was found in 2003,
and by the end of 2008 nearly 42% of all newly identified MRSA
in humans reported to the National Institute of Public Health and
the Environment in the Netherlands were MRSA CC398 (www.
rivm.nl/mrsa). Approximately one third of people who are in
direct contact with pigs and veal calves carry MRSA [29] and
there is no indication that the extensive reservoir in animals can be
brought under control in the near future. S. aureus CC398 is a
clonal complex that has been associated with pigs and pig farmers
before [28]. Our results indicated that S. aureus CC398 might be an
increasing cause of invasive staphylococcal disease. These results
are in line with other findings that certain S. aureus CC398 isolates,
especially spa-type t571, can cause invasive infections in humans
[12,18,21,22,27]. This human-adapted CC398 subclone is now
increasingly identified in hospitals [20]. It appears to be highly
receptive for horizontal gene transfer [30]. Therefore, further
adaptation to humans may occur and if S. aureus CC398 can
successfully spread from human to human it may pose a significant
public health problem in the future. In addition, further
acquisition of genetic elements harboring virulence and antibiotic
resistance could arise. Therefore, careful monitoring of the
evolution and epidemiology of MRSA CC398 is important.
Acknowledgments
The authors thank Veronica Weterings and Jolanda van Baal-Visser for
performing the 16S–23S spacer region PCRs and gel electrophoresis, as
well as Marie-Louise van Leest for developing and optimizing the real-time
S. aureus specific and CC398 specific PCR.
Author Contributions
Conceived and designed the experiments: EV A. Bergmans JK. Performed
the experiments: EV A. Bergmans. Analyzed the data: EV. Contributed
reagents/materials/analysis tools: EV A. Bergmans A. Budding A. van
Belkum PS A. Buiting JK. Wrote the paper: EV JK.
References
1. Diederen BM, Kluytmans JA (2006) The emergence of infections with
community-associated methicillin-resistant Staphylococcus aureus. J Infect 3: 157–
168.
2. Kluytmans-Vandenbergh MF, Kluytmans JA (2006) Community-acquired
methicillin-resistant Staphylococcus aureus: current perspectives. Clin Microbiol
Infect 12 (Suppl. 1): 9–15.
3. Voss A, Loeffen F, Bakker J, Klaassen C, Wulf M (2005) Methicillin-resistant
Staphylococcus aureus in pig farming. Emerg Infect Dis 11: 1965–1966.
4. van den Broek IVF, van Cleef BAGL, Haenen A, Broens EM, van der Wolf PJ,
et al. (2009) Methicillin-resistant Staphylococcus aureus in people living and working
in pig farms. Epidemiol Infect 137: 700–708.
5. de Neeling AJ, van den Broek MJ, Spalburg EC, van Santen-Verheuvel MC,
Dam-Deisz DC, et al. (2007) High prevalence of methicillin-resistant
Staphylococcus aureus in pigs. Vet Microbiol 122: 366–372.
6. van Loo I, Huijsdens X, Tiemersma E, de Neeling A, van de Sande-Bruinsma
N, et al. (2007) Emergence of methicillin-resistant Staphylococcus aureus of animal
origin in humans. Emerg Infect Dis 13: 1834–1839.
7. Dolzani L, Tonin E, Lagatolla C, Monti-Bragadin C (1994) Typing of
Staphylococcus aureus by amplification of the 16S–23S rRNA intergenic spacer
sequences. FEMS Microbiol Lett 119: 167–173.
8. Schmitz FJ, Ja¨ger B, Tichy HV, Idel H, Hadding U, et al. (1997) Insertion
possibility of 16S–23S space amplification and random amplified polymorphic
DNA analysis for typing of methicillin-resistant Staphylococcus aureus strains in the
context of nosocomial infections. Zentralbl Hyg Umweltmed 200: 172–188.
9. Melles DC, van Leeuwen WB, Snijders SV, Horst-Kreft D, Peeters JK, et al.
(2007) Comparison of multilocus sequence typing (MLST), pulsed-field gel
electrophoresis (PFGE), and amplified fragment length polymorphism (AFLP)
for genetic typing of Staphylococcus aureus. J Microbiol Methods 69: 371–375.
10. Schmitz FJ, Steiert M, Tichy HV, Hofmann B, Verhoef J, et al. (1998) Typing of
methicillin-resistant Staphylococcus aureus isolates from Dusseldorf by six genotypic
methods. J Med Microbiol 47: 341–351.
11. van Wamel WJ, Hansenova´ Mana´skova´ S, Fluit AC, Verbrugh H, de Neeling
AJ, et al. (2010) Short term micro-evolution and PCR-detection of methicillin-
resistant and -susceptible Staphylococcus aureus sequence type 398. Eur J Clin
Microbiol Infect Dis 29: 119–122.
12. van Belkum A, Melles DC, Peeters JK, van Leeuwen WB, van Duijkeren E, et al
(2008) Methicillin-resistant and -susceptible Staphylococcus aureus sequence type
398 in pigs and humans. Emerg Infect Dis 14: 479–483.
13. CBS Statistics Netherlands Annual count of farming 2005–2007. Available: at:
http://www.cbs.nl. Accessed: 21 April 2008.
14. National Committee for Clinical Laboratory Standards (2006) Performance
standards for antimicrobial susceptibility testing. Approved standard M100-S16.
National Committee for Clinical Laboratory Standards, Wayne, Pa.
15. Budding AE, Vandenbroucke-Grauls CMJE, van Duijkeren E, Kluytmans JA,
Savelkoul PHM (2010) Binary IS typing for Staphylococcus aureus. PLoS One
5(10):e13671. doi:10.1371/journal.pone.0013671.
16. Harmsen D, Claus H, Witte W, et al. (2003) Typing of methicillin-resistant
Staphylococcus aureus in a university hospital setting by using novel software for spa
repeat determination and database management. J Clin Microbiol; 41:5442–8.
17. Bhat M, Dumortier C, Taylor B, Miller M, Vasquez G, et al. (2009) Staphylococcus
aureus ST398, New York City and Dominican Republic. Emerg Infect Dis 15:
285–287.
18. Uhlemann A, Porcella SF, Trivedi S, Sullivan SB, Hafer C, et al. (2012)
Identification of a highly transmissible animal-independent Staphylococcus aureus
ST398 clone with distinct genomic and cell adhesion properties. mBio 3:
e00027-12.
19. Jimenez JN, Velez LA, Mediavilla JR, Ocampo AM, Vanegas JM, et al. (2011)
Livestock-associated methicillin-susceptible Staphylococcus aureus ST398 infection
in woman, Colombia. Emerg Infect Dis 17: 1970–1971
20. van der Mee-Marquet N, Franc¸ois P, Domelier AS, Coulomb F, Decreux C,
et al. for the Bloodstream Infection Study Group of the Re´seau des Hygie´nistes
de Centre (RHC) (2011) Emergence of unusual bloodstream infections
associated with pig-borne-like Staphylococcus aureus ST398 in France. Clin Infect
Dis 52: 152–153.
Emergence of S. aureus CC398 in Blood Cultures
PLOS ONE | www.plosone.org 4 October 2012 | Volume 7 | Issue 10 | e41855
21. Price LB, Stegger M, Hasman H, Aziz M, Larsen J, et al. (2012) Staphylococcus
aureus CC398: host adaptation and emergence of methicillin resistance in
livestock. MBio 3: e00305-11.
22. Valentin-Domelier AS, Girard M, Bertrand X, Violette J, Franc¸ois P, et al. for
the Bloodstream Infection Study Group of the Re´seau des Hygie´nistes de Centre
(RHC) (2011) Methicillin-resistant ST398 Staphylococcus aureus responsible for
bloodstream infections: an emerging human-adapted subclone? PLoS One
6(12):e28369. doi:10.1371/journal.pone.0028369.
23. Cuny C, Nathaus R, Layer F, Strommenger B, Altmann D, et al. (2009) Nasal
colonization of humans with methicillin-resistant Staphylococcus aureus (MRSA)
CC398 with and without exposure to pigs. PLoS ONE 4(8): e6800. doi:10.1371/
journal.pone.0006800
24. Wassenberg MW, Bootsma MC, Troelstra A, Kluytmans JA, Bonten MJ (2011)
Transmissibility of livestock-associated methicillin-resistant Staphylococcus aureus
(ST398) in Dutch hospitals. Clin Microbiol Infect 17: 316–319.
25. van Rijen MM, van Keulen PH, Kluytmans JAJ (2008) Increase in a Dutch
hospital of methicillin-resistant Staphylococcus aureus related to animal farming.
Clin Inf Dis 46: 261–263.
26. Ekkelenkamp MB, Sekkat M, Carpaij N, Troelstra A, Bonten MJ (2006)
Endocarditis due to methicillin-resistant Staphylococcus aureus originating from pigs
[in Dutch]. Ned Tijdschr Geneeskd 150: 2442–2447.
27. Rasigade JP, Laurent F, Hubert P, Vandenesch F, Etienne J (2010) Lethal
necrotizing pneumonia caused by an ST398 Staphylococcus aureus strain. Emerg
Infect Dis 16: 1330.
28. Armand-Lefevre L, Ruimy R, Andremont A (2005) Clonal comparison of
Staphylococcus aureus isolates from healthy pig farmers, human controls, and pigs.
Emerg Infect Dis 11: 711–714.
29. Vandenbroucke-Grauls CM, Beaujean DJ (2006) Methicillin-resistant Staphylo-
coccus aureus in pig breeders and cattle breeders [in Dutch]. Ned Tijdschr
Geneeskd 150: 1710–1712.
30. Waldron D, Lindsay J (2006) Sau1: a novel lineage-specific type I restriction-
modification system that blocks horizontal gene transfer into Staphylococcus aureus
and between Staphylococcus aureus isolates of different lineages. J Bacteriol 188:
5578–5585.
Emergence of S. aureus CC398 in Blood Cultures
PLOS ONE | www.plosone.org 5 October 2012 | Volume 7 | Issue 10 | e41855
